Exact Sciences Stock Rises After FDA Signs Off On New Cologuard
In this article:
Exact Sciences stock rose Friday after the FDA approved the company's next-generation colon cancer detection test, Cologuard Plus.
Advertisement
Exact Sciences stock rose Friday after the FDA approved the company's next-generation colon cancer detection test, Cologuard Plus.